CoChat

A novel screening workflow for nitazene analogs using LC–MS/MS precursor ion scan acquisition

Pacana, Amanda L, Skillman, Britni N · 2025 · Journal of Analytical Toxicology

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

A persistent problem in the detection of novel psychoactive substances (NPS) is the inability of traditional screening methodologies to rapidly adapt to evolving drug trends. As such, high-resolution mass spectrometry (HRMS) screening methods have gained popularity in recent years for the ability to use non-targeted acquisition to detect a wide variety of compounds without necessarily returning to method development. However, these instruments may be unattainable for some forensic laboratories due to the associated high capital costs. The described method provides an alternative screening method using precursor ion scan (PIS) acquisition on a liquid chromatography–tandem mass spectrometry (LC–MS/MS) platform to screen for nitazene analogs. Four ions were evaluated (m/z 72.1, 98.0, 100.1, and 112.1) for d0 analytes and one ion (m/z 104.1) for the metodesnitazene-d4 internal standard. Using a liquid–liquid extraction in whole blood, the method was validated with a 0.5 ng/mL limit of detection and 1.0 ng/mL administrative cutoff. Observed matrix effects did not affect limit of detection and there was no demonstration of carryover or interferences. As a proof-of-concept study, authentic (n = 3) and blind fortified (n = 20) samples were evaluated using this method, which was able to identify all nitazenes with no false negatives or positives. Several nitazenes not initially included in the scope of method development or validation were also presumptively identified. To accommodate this novel instrumental analysis, a workflow is also proposed to assist in the identification of known and emerging nitazene analogs. LC–MS/MS is widely available among forensic laboratories and presents a viable alternative to HRMS screening for nitazene analogs when operated in PIS acquisition, in such cases that HRMS is unavailable for assessing emerging NPS threats.

Overview

Integrity signals

Registry

Crossref · 10.1093/jat/bkaf046

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Krotulski, 2020, Emerging synthetic cannabinoids: development and validation of a novel liquid chromatography time-of-flight mass spectrometry assay for real-time detection, J Anal Toxicol, 00, 1

Cited by

See all 8

Metadata

Authors
Pacana, A. L., & Skillman, B. N.
Affiliations
Sam Houston State University (US)
Corresponding author
Skillman, Britni N
Venue
Journal of Analytical Toxicology
Published
2025-05-26
Volume
49
Issue
8
Pages
520-528
ISSN
  • 0146-4760 (ISSN-L)
  • 1945-2403
OpenAlex
W4410761039
Cited by
8
References
13
Citations by year
2026: 6 · 2025: 2
FWCI
4.10
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Analytical Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
Keywords
new psychoactive substances, precursor ion scan, LC-MS/MS screening, forensic toxicology, blood analysis, liquid-liquid extraction, method validation, presumptive identification
MeSH terms
Liquid Chromatography-Mass Spectrometry, Chromatography, Liquid, Humans, Psychotropic Drugs, Reproducibility of Results, Substance Abuse Detection, Tandem Mass Spectrometry, Workflow, Limit of Detection, Liquid-Liquid Extraction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.